Immuno US 2024
October 2024 | San Diego, CA
Delivering advanced, commercially viable immunotherapies to meet unmet medical need
Explore Immuno US 2024: Facilitating the Next Generation of Advanced Immunotherapies
Join a like-minded community of over 400 scientists & business leaders committed to accelerating the development & approval of advanced immunotherapies to address unmet medical needs.
Deep-dive into the most need-to-know data, technologies and strategies in drug discovery, clinical development & manufacturing across multiple modalities, from novel cell therapies and therapeutic antibodies, to oncolytic viruses and the microbiome. From the big-picture challenges in the regulation and commercialization of these novel products through to the technical considerations affecting each stage of the development pipeline, Immuno US highlights the tools you need to fast-track your product development. Alongside presentations and panel discussions, the conference features a host of formal and informal networking opportunities allowing you to foster long-term collaborations and meet the right partners for your research goals.
Immuno US 2024
- Gain insights into emerging immune-targeting modalities with the potential to transform patient care, including cell & gene therapies, therapeutic antibodies, vaccines & oncolytic viruses
- Take a deep dive into translational & pre-clinical development with discussions on animal modelling techniques and screening strategies to assess safety and efficacy
- Ensure your late stage development is set up for success. Streamline your route through the clinic with the successful implementation of effective trial design strategies, and ensure scalability of your product
Agenda at a Glance
- Day One, Track 1: Discovery & Validation of Novel Modalities – Cell & Gene Therapy
- Day One, Track 2: Discovery & Validation of Novel Modalities – Microbiome & the Gut-Immune Axis
- Day One, Track 3: Biomarkers & Multi-Omics For Precision Oncology & Immunology
- Day One, Track 4: Designing Clinical Trials for Success
- Day Two, Track 1: Discovery & Validation of Novel Modalities – Therapeutic Antibodies
- Day Two, Track 2: Discovery & Validation of Novel Modalities – Oncolytic Viruses & Cancer Vaccines
- Day Two, Track 3: Predictive Models & Tools for Preclinical Evaluation
- Day Two, Track 4: Manufacturing Novel Products at Scale
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences
-
Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
-
Global Technological Showcase
An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field. -
Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections -
Innovative Poster Displays
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions
Companies Represented Include
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Immuno US 2023: 12 - 13 October 2023, San Diego, USA
All Speakers
Meet Our Esteemed Sponsors
Silver Sponsors
Network & Programme Sponsors
Sponsors of last year's event included
Interested in Sponsoring?
Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.
Learn moreLatest Resources
How to Improve Therapeutic Efficacy: Safety Considerations in Oncolytic Virotherapy
Zika Virus Tested as an Effective Oncolytic Agent for Glioblastoma in In Vitro Models
Post-Event Proceedings – Immuno 2023
In Vivo Models Show Survival Promise for Zika Oncolytic Viral Therapy for Neuroblastoma
New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development
Uncovering Mechanisms of Immunotherapy Response & Resistance with Single Cell & Spatial Multiomics
Register Your Interest
Submit your details and a member of our team will be in touch